Hematologic Agents [Pharmacological Action]
Tree Number(s): D006401
MeSH Unique ID: D006401
- voxelotor (Supplementary Concept)
- zanubrutinib (Supplementary Concept)
- Filgrastim (MeSH Term)
- Lenograstim (MeSH Term)
- fluindione (Supplementary Concept)
- tocopherylquinone (Supplementary Concept)
- bromadiolone (Supplementary Concept)
- tanshinone (Supplementary Concept)
- aprosulate (Supplementary Concept)
- efegatran (Supplementary Concept)
- PENTA (Supplementary Concept)
- CPDA solutions (Supplementary Concept)
- danaparoid (Supplementary Concept)
- lamifiban (Supplementary Concept)
- (2S)-2-(4-(((3S)-1-acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphtyl)propanoic acid (Supplementary Concept)
- nitrophorin (Supplementary Concept)
- acid citrate dextrose (Supplementary Concept)
- moxicoumone (Supplementary Concept)
- troxerutin (Supplementary Concept)
- clocoumarol (Supplementary Concept)
- calcium heparin (Supplementary Concept)
- N(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide (Supplementary Concept)
- lipoprotein-associated coagulation inhibitor (Supplementary Concept)
- antistasin (Supplementary Concept)
- nafamostat (Supplementary Concept)
- certoparin (Supplementary Concept)
- bemiparin (Supplementary Concept)
- coumachlor (Supplementary Concept)
- fibrinogen fragment X (Supplementary Concept)
- chlorophacinone (Supplementary Concept)
- ferulic acid (Supplementary Concept)
- protocatechualdehyde (Supplementary Concept)
- desirudin (Supplementary Concept)
- parnaparin (Supplementary Concept)
- plumbagin (Supplementary Concept)
- ardeparin (Supplementary Concept)
- reviparin (Supplementary Concept)
- citrate phosphate dextrose (Supplementary Concept)
- fucoidan (Supplementary Concept)
- glucuronyl glucosamine glycan sulfate (Supplementary Concept)
- laminaran (Supplementary Concept)
- difenacoum (Supplementary Concept)
- bromfenacoum (Supplementary Concept)
- enoxaparin sodium (Supplementary Concept)
- glenzocimab (Supplementary Concept)
- idrabiotaparinux (Supplementary Concept)
- antivitamins K (Supplementary Concept)
- bivalirudin (Supplementary Concept)
- melagatran (Supplementary Concept)
- argatroban (Supplementary Concept)
- lepirudin (Supplementary Concept)
- SDZ MTH 958 (Supplementary Concept)
- inogatran (Supplementary Concept)
- ximelagatran (Supplementary Concept)
- 6-methyl-1,2,3,5-tetrahydroimidazo(2,1-b)quinazolin-2-one hydrochloride (Supplementary Concept)
- HY023016 (Supplementary Concept)
- pyragrel (Supplementary Concept)
- tick anticoagulant peptide (Supplementary Concept)
- ITF 1331 (Supplementary Concept)
- SEL 2711 (Supplementary Concept)
- YM 60828 (Supplementary Concept)
- FX 2212 (Supplementary Concept)
- PD0313052 (Supplementary Concept)
- WX-FX4 compound (Supplementary Concept)
- 6-chloromethyl-3-(2,5-dichlorophenoxycarbonyl)-2-benzopyrone (Supplementary Concept)
- 3,3'-(3,5-difluoro-4-methyl-2,6-pyridinediylbis(oxy))bis(benzenecarbox(imide)amide) (Supplementary Concept)
- SF 324 (Supplementary Concept)
- RPR 130737 (Supplementary Concept)
- BnSO(2)-D-Arg-Gly-Arg-ketothiazole (Supplementary Concept)
- lefaxin (Supplementary Concept)
- N(2)-(4-(dimethylamino)benzoyl)-4-hydroxy-N(1)-(4-methoxybenzoyl)-1,2-benzenediamine (Supplementary Concept)
- 2-(4-(dimethylamino)benzoylamino)-5-methanesulfonylamino-N'-(4-methoxyphenyl)benzamide (Supplementary Concept)
- RPR 208566 (Supplementary Concept)
- N-(4-chlorophenyl)-N-(2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide (Supplementary Concept)
- 3-chloro-N-(4-chloro-2-(((5-chloro-2-pyridinyl)amino)carbonyl)-6-methoxyphenyl)-4-((methylamino)methyl)-2-thiophenecarboxamide (Supplementary Concept)
- 3-chloro-N-(4-chloro-2-(((5-chloro-2-pyridinyl)amino)carbonyl)-6-methoxyphenyl)-4-(((4,5-dihydro-2-oxazolyl)methylamino)methyl)-2-thiophenecarboxamide (Supplementary Concept)
- 2-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)propanoyl)piperidin-4-yl)-5-methyl-1,2-dihydro-3H-imidazo(1,5-c)imidazol-3-one (Supplementary Concept)
- 2-(5-chlorothien-2-yl)-N-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide (Supplementary Concept)
- ZK 806299 (Supplementary Concept)
- DPC 602 (Supplementary Concept)
- RPR 209685 (Supplementary Concept)
- 1-(1-amino-7-isoquinolyl)-N-(2'-(aminosulfonyl)-1,1'-biphenyl-4-yl)-3-methyl-1H-pyrazole-5-carboxamide (Supplementary Concept)
- idraparinux (Supplementary Concept)
- edoxaban (Supplementary Concept)
- 1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one (Supplementary Concept)
- Amblyomin-X protein, Amblyomma cajennense (Supplementary Concept)
- darexaban (Supplementary Concept)
- factor Xa, Glu-Gly-Arg- (Supplementary Concept)
- 1-(2,2-difluoroethyl)pyrrolidine-3,4-dicarboxylic acid 3-((5-chloropyridin-2-yl)amide) 4-((2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl)amide) (Supplementary Concept)
- SV-66 protein, Simulium vittatum (Supplementary Concept)
- lufaxin protein, Lutzomyia longipalpis (Supplementary Concept)
- therostasin protein, Theromyzon tessulatum (Supplementary Concept)
- 3-(4-(5-(2,6-dimethyltetrahydro-1(2H)-pyridinyl)pentyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl)-1-benzenecarboximidamide (Supplementary Concept)
- SE 170 (Supplementary Concept)
- 1-(3-(aminomethyl)phenyl)-N-(3-fluoro-2'-(methylsulfonyl)(1,1'-biphenyl)-4-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (Supplementary Concept)
- otamixaban (Supplementary Concept)
- alpha-(3-amidinylphenoxy)-2-bromo-N-(5-(pyrrolidin-1-ylcarbonyl)phenyl)phenylacetamide (Supplementary Concept)
- 4-((2-amidino-1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl)-1-(4-pyridinyl)piperidine-4-carboxylic acid monomethanesulfonate trihydrate (Supplementary Concept)
- eisenstasin (Supplementary Concept)
- N-(4-(1-(acetimidoyl)piperidin-4-yloxy)-3-carbamoylphenyl)-N-(3-(3-amidinophenyl)-2-fluoro-2-propenyl)sulfamoylacetic acid (Supplementary Concept)
- 1-(3-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-6-(2'-(3-hydroxy-N-pyrrolidinyl)methyl-(1,1')-biphen-4-yl)-1,4,5,6-tetrahydropyrazolo-(3,4-c)-pyridin-7-one (Supplementary Concept)
- RWJ 445167 (Supplementary Concept)
- apixaban (Supplementary Concept)
- betrixaban (Supplementary Concept)
- BMS 269223 (Supplementary Concept)
- 6-(dimethylcarbamoyl)nicotinoyl guanidine (Supplementary Concept)
- 3-(4-(5-(2,6-dimethylpiperidin-1-yl)pentyl)-3-oxo-3,4-dihydroxyquinoxalin-2-yl)benzamidine (Supplementary Concept)
- 2-carbamoyl-4-((6-chloronaphthalen-2-yl)sulfonyl)-1-((5-methyl-4,5,6,7-tetrahydrothiazolo(5,4-c)pyridin-2-yl)carbonyl)piperazine (Supplementary Concept)
- ZK 805412 (Supplementary Concept)
- RPR 120844 (Supplementary Concept)
- isoleucyl-glutamyl-glycyl-arginine chloromethyl ketone (Supplementary Concept)
- 5-chlorothiophene-2-carboxylic acid (2-(2-methyl-3-(2-oxopyrrolidin-1-yl)benzenesulfonylamino)-3-(4-methylpiperazin-1-yl)-3-oxopropyl)amide (Supplementary Concept)
- cetiedil (Supplementary Concept)
- 5-(2-formyl-3-hydroxyphenoxy)pentanoic acid (Supplementary Concept)
- methyl isocyanate (Supplementary Concept)
- efaproxiral (Supplementary Concept)
- Ultroser G (Supplementary Concept)
- HBOC 201 (Supplementary Concept)
- plasma protein fraction (Supplementary Concept)
- BAX 855 (Supplementary Concept)
- anti-inhibitor coagulant complex (Supplementary Concept)
- ristocetin A (Supplementary Concept)
- physarumin (Supplementary Concept)
- cold agglutinins (Supplementary Concept)
- erythrina lectin (Supplementary Concept)
- Non-Ovlon (Supplementary Concept)
- Lugol's solution (Supplementary Concept)
- aminaftone (Supplementary Concept)
- pitressin tannate (Supplementary Concept)
- carbazochrome (Supplementary Concept)
- bismuth subgallate (Supplementary Concept)
- adrenalone (Supplementary Concept)
- ethyl 2-cyanoacrylate (Supplementary Concept)
- menatetrenone (Supplementary Concept)
- bone wax (Supplementary Concept)
- naftazone (Supplementary Concept)
- menaquinone 7 (Supplementary Concept)
- amylase, phosphates, proteases drug combinations (Supplementary Concept)
- Surgiflo (Supplementary Concept)
- CEGP-003 (Supplementary Concept)
- polyvinyl alcohol formaldehyde foam (Supplementary Concept)
- ferric subsulfate solution (Supplementary Concept)
- 6-carboxycellulose (Supplementary Concept)
- IIS-PAA (Supplementary Concept)
- 4-aminomethylbenzoic acid (Supplementary Concept)
- fibrin fragment D (Supplementary Concept)
- low affinity platelet factor 4 (Supplementary Concept)
- nafazatrom (Supplementary Concept)
- ecarin (Supplementary Concept)
- anagrelide (Supplementary Concept)
- salivary plasminogen activator alpha 1, Desmodus rotundus (Supplementary Concept)
- sarpogrelate (Supplementary Concept)
- ozagrel (Supplementary Concept)
- nitroaspirin (Supplementary Concept)
- pamiteplase (Supplementary Concept)
- reteplase (Supplementary Concept)
- SR 46349B (Supplementary Concept)
- defibrotide (Supplementary Concept)
- WEB 2086 (Supplementary Concept)
- sulotroban (Supplementary Concept)
- 9-O-methanoprostaglandin I (Supplementary Concept)
- abietic acid (Supplementary Concept)
- benzarone (Supplementary Concept)
- fibrin destabilase (Supplementary Concept)
- isbogrel (Supplementary Concept)
- ginkgolide B (Supplementary Concept)
- semuloparin (Supplementary Concept)
- vapiprost (Supplementary Concept)
- monteplase (Supplementary Concept)
- snake venom protein C activator (Supplementary Concept)
- Y 20811 (Supplementary Concept)
- isaridin E (Supplementary Concept)
- acetylphenylalanyl-prolyl-boroarginine (Supplementary Concept)
- saruplase (Supplementary Concept)
- kistrin (Supplementary Concept)
- asarone (Supplementary Concept)
- higenamine (Supplementary Concept)
- luspatercept (Supplementary Concept)
- ferric gluconate (Supplementary Concept)
- ferrous succinate (Supplementary Concept)
- iron protein succinylate (Supplementary Concept)
- iron isomaltoside 1000 (Supplementary Concept)
- ferric maltol (Supplementary Concept)
- hexamethylene bisacetamide (Supplementary Concept)
- teferrol (Supplementary Concept)
- TKN732 (Supplementary Concept)
- ferrous gluconate (Supplementary Concept)
- acetylsalicylic acid lysinate (Supplementary Concept)
- essential 303 forte (Supplementary Concept)
- picotamide (Supplementary Concept)
- 1,2-benzisothiazoline-3-one (Supplementary Concept)
- triflusal (Supplementary Concept)
- plafibride (Supplementary Concept)
- ramatroban (Supplementary Concept)
- 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole (Supplementary Concept)
- bepafant (Supplementary Concept)
- enfenamic acid (Supplementary Concept)
- indobufen (Supplementary Concept)
- diadenosine tetraphosphate (Supplementary Concept)
- 12-HPETE (Supplementary Concept)
- cilostamide (Supplementary Concept)
- S-nitrosocysteine (Supplementary Concept)
- emoxypine succinate (Supplementary Concept)
- triflavin (Supplementary Concept)
- Foropafant (Supplementary Concept)
- rhodostomin (Supplementary Concept)
- draflazine (Supplementary Concept)
- naftopidil (Supplementary Concept)
- Ro 31-7549 (Supplementary Concept)
- Ro 31-8220 (Supplementary Concept)
- N-acetylsphingosine (Supplementary Concept)
- eicosapentaenoic acid ethyl ester (Supplementary Concept)
- Quin2 (Supplementary Concept)
- ataprost (Supplementary Concept)
- dauricine (Supplementary Concept)
- trequinsin (Supplementary Concept)
- sibrafiban (Supplementary Concept)
- DMP 728 (Supplementary Concept)
- 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole (Supplementary Concept)
- xemilofiban (Supplementary Concept)
- E 4021 (Supplementary Concept)
- linsidomine (Supplementary Concept)
- pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid (Supplementary Concept)
- ifetroban (Supplementary Concept)
- IH 764-3 (Supplementary Concept)
- aloxistatin (Supplementary Concept)
- 3,4-dihydroxyphenylethanol (Supplementary Concept)
- CV 3988 (Supplementary Concept)
- ibudilast (Supplementary Concept)
- dazmegrel (Supplementary Concept)
- piroximone (Supplementary Concept)
- daltroban (Supplementary Concept)
- tautomycin (Supplementary Concept)
- cloricromen (Supplementary Concept)
- S-nitrosomercaptoethanol (Supplementary Concept)
- 3,4-dihydroxyacetophenone (Supplementary Concept)
- 3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate (Supplementary Concept)
- 4,5-dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone (Supplementary Concept)
- diallyl trisulfide (Supplementary Concept)
- carboprostacyclin (Supplementary Concept)
- 3-n-butylphthalide (Supplementary Concept)
- clopidogrel carboxylic acid (Supplementary Concept)
- vorapaxar (Supplementary Concept)
- oxophenylarsine (Supplementary Concept)
- andrographolide (Supplementary Concept)
- glycocalicin (Supplementary Concept)
- pycnogenols (Supplementary Concept)
- thromboxane A2, carbocyclic (Supplementary Concept)
- 8-((4-chlorophenyl)thio)cyclic-3',5'-GMP (Supplementary Concept)
- RS 5186 (Supplementary Concept)
- S 145 (Supplementary Concept)
- clentiazem (Supplementary Concept)
- canadine (Supplementary Concept)
- magnolol (Supplementary Concept)
- tesmilifene (Supplementary Concept)
- UD CG 212 Cl (Supplementary Concept)
- beraprost (Supplementary Concept)
- ridogrel (Supplementary Concept)
- 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (Supplementary Concept)
- ST 638 (Supplementary Concept)
- FK 409 (Supplementary Concept)
- MP407 (Supplementary Concept)
- policosanol (Supplementary Concept)
- relcovaptan (Supplementary Concept)
- GEA 3162 (Supplementary Concept)
- 1,2-dipalmitoyl-3-phosphatidylethanolamine (Supplementary Concept)
- arginyl-glycyl-aspartyl-serine (Supplementary Concept)
- Satigrel (Supplementary Concept)
- echistatin (Supplementary Concept)
- BW A868C (Supplementary Concept)
- atrinositol (Supplementary Concept)
- protopine (Supplementary Concept)
- trilinolein (Supplementary Concept)
- 6-methyl-2-ethyl-3-hydroxypyridine (Supplementary Concept)
- ajoene (Supplementary Concept)
- glycyl-arginyl-glycyl-aspartyl-serine (Supplementary Concept)
- 1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one (Supplementary Concept)
- alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol (Supplementary Concept)
- ONO 3708 (Supplementary Concept)
- helenalin (Supplementary Concept)
- JLX001 (Supplementary Concept)
- S007-867 (Supplementary Concept)
- BMS-986120 (Supplementary Concept)
- cangrelor (Supplementary Concept)
- KW 3635 (Supplementary Concept)
- BN 50730 (Supplementary Concept)
- TCV 309 (Supplementary Concept)
- fibrinopeptides gamma (Supplementary Concept)
- tranilast (Supplementary Concept)
- Pentosan Sulfuric Polyester (MeSH Term)
- Acenocoumarol (MeSH Term)
- Protein C (MeSH Term)
- Dermatan Sulfate (MeSH Term)
- Dextrans (MeSH Term)
- Dicumarol (MeSH Term)
- Protein S (MeSH Term)
- Nadroparin (MeSH Term)
- Enoxaparin (MeSH Term)
- Dalteparin (MeSH Term)
- Citric Acid (MeSH Term)
- Blood Coagulation Factor Inhibitors (MeSH Term)
- Fibrin Fibrinogen Degradation Products (MeSH Term)
- Ancrod (MeSH Term)
- Edetic Acid (MeSH Term)
- Ethyl Biscoumacetate (MeSH Term)
- Heparin (MeSH Term)
- Heparin, Low-Molecular-Weight (MeSH Term)
- Heparinoids (MeSH Term)
- Warfarin (MeSH Term)
- 4-Hydroxycoumarins (MeSH Term)
- beta 2-Glycoprotein I (MeSH Term)
- Phenindione (MeSH Term)
- Phenprocoumon (MeSH Term)
- Becaplermin (MeSH Term)
- Abciximab (MeSH Term)
- Gabexate (MeSH Term)
- Tinzaparin (MeSH Term)
- Sodium Citrate (MeSH Term)
- Heparin Cofactor II (MeSH Term)
- Dabigatran (MeSH Term)
- Antithrombin III (MeSH Term)
- Hirudins (MeSH Term)
- Antithrombin Proteins (MeSH Term)
- Rivaroxaban (MeSH Term)
- Fondaparinux (MeSH Term)
- Precipitins (MeSH Term)
- Dimethyl Adipimidate (MeSH Term)
- Hydroxyurea (MeSH Term)
- Polygeline (MeSH Term)
- Povidone (MeSH Term)
- Hydroxyethyl Starch Derivatives (MeSH Term)
- Kallikreins (MeSH Term)
- Coagulase (MeSH Term)
- Plasma Kallikrein (MeSH Term)
- Factor VIII (MeSH Term)
- Platelet Factor 3 (MeSH Term)
- Platelet Factor 4 (MeSH Term)
- Lectins (MeSH Term)
- Plant Lectins (MeSH Term)
- Phytohemagglutinins (MeSH Term)
- Hemagglutinin Glycoproteins, Influenza Virus (MeSH Term)
- Calcium Dobesilate (MeSH Term)
- Fibrin Tissue Adhesive (MeSH Term)
- Thrombin (MeSH Term)
- Thromboplastin (MeSH Term)
- Tolonium Chloride (MeSH Term)
- Aprotinin (MeSH Term)
- Lypressin (MeSH Term)
- Deamino Arginine Vasopressin (MeSH Term)
- Ornipressin (MeSH Term)
- Fibrin Foam (MeSH Term)
- Gelatin Sponge, Absorbable (MeSH Term)
- Arginine Vasopressin (MeSH Term)
- Batroxobin (MeSH Term)
- Ethamsylate (MeSH Term)
- Cellulose, Oxidized (MeSH Term)
- Vasopressins (MeSH Term)
- Chitosan (MeSH Term)
- Tranexamic Acid (MeSH Term)
- alpha-2-Antiplasmin (MeSH Term)
- Vitamin K (MeSH Term)
- Aminocaproic Acid (MeSH Term)
- Vitamin K 2 (MeSH Term)
- Vitamin K 3 (MeSH Term)
- Vitamin K 1 (MeSH Term)
- Protamines (MeSH Term)
- Hexadimethrine Bromide (MeSH Term)
- Anistreplase (MeSH Term)
- Ticlopidine (MeSH Term)
- Brinolase (MeSH Term)
- Fibrinolysin (MeSH Term)
- Aspirin (MeSH Term)
- Streptokinase (MeSH Term)
- Plasminogen (MeSH Term)
- Tissue Plasminogen Activator (MeSH Term)
- Tenecteplase (MeSH Term)
- Cilostazol (MeSH Term)
- Tirofiban (MeSH Term)
- Darbepoetin alfa (MeSH Term)
- Epoetin Alfa (MeSH Term)
- Iron-Dextran Complex (MeSH Term)
- Liver Extracts (MeSH Term)
- Ferric Compounds (MeSH Term)
- Folic Acid (MeSH Term)
- Hydroxocobalamin (MeSH Term)
- Ferrosoferric Oxide (MeSH Term)
- Ferric Oxide, Saccharated (MeSH Term)
- Iloprost (MeSH Term)
- Pentoxifylline (MeSH Term)
- Trapidil (MeSH Term)
- Aspirin, Dipyridamole Drug Combination (MeSH Term)
- Prasugrel Hydrochloride (MeSH Term)
- Ketanserin (MeSH Term)
- Epoprostenol (MeSH Term)
- Disintegrins (MeSH Term)
- Milrinone (MeSH Term)
- Alprostadil (MeSH Term)
- Dipyridamole (MeSH Term)
- S-Nitrosothiols (MeSH Term)
- S-Nitrosoglutathione (MeSH Term)
- Clopidogrel (MeSH Term)
- Sevoflurane (MeSH Term)
- Resveratrol (MeSH Term)
- Ticagrelor (MeSH Term)
- Eptifibatide (MeSH Term)